[1]韩孝洲 赵诚① 邱瑾② 刘剑新 林钐**② 张勇 田长海 刘旺 胡华军.输尿管软镜引导腹膜透析管置入的比较研究[J].中国微创外科杂志,2024,01(1):29-33.
　Han Xiaozhou*,Zhao Cheng,Qiu Jin,et al.Comparative Study on Flexible Ureteroscope Guided Peritoneal Dialysis Catheter Placement[J].Chinese Journal of Minimally Invasive Surgery,2024,01(1):29-33.
点击复制

输尿管软镜引导腹膜透析管置入的比较研究()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2024年1期
页码:
29-33
栏目:
临床研究
出版日期:
2024-01-25

文章信息/Info

Title:
Comparative Study on Flexible Ureteroscope Guided Peritoneal Dialysis Catheter Placement
作者:
韩孝洲 赵诚① 邱瑾② 刘剑新 林钐**② 张勇 田长海 刘旺 胡华军
(上海中医药大学附属上海市中西医结合医院泌尿外科，上海200082)
Author(s):
Han Xiaozhou*;  Zhao Cheng;  Qiu Jin;  et al.
*Urology Department, Shanghai TCMIntegrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China
关键词:
腹膜透析; 输尿管软镜; 置管
Keywords:
Peritoneal dialysis; Flexible ureteroscope; Catheter placement
文献标志码:
A
摘要:
目的探讨输尿管软镜引导腹膜透析管(腹透管)置入的可行性。方法回顾性分析2019年5月~2023年3月终末期肾病54例腹透管置入的临床资料，由患者选择置入方法，常规组23例应用金属导丝引导腹透管置入，软镜组31例应用输尿管软镜代替导丝引导腹透管置入。比较2组手术成功率、手术时间、术后应用止痛药、腹透管相关并发症和术后肌酐下降等指标。结果2组均置管成功，软镜组腹透管相关并发症总发生率低于常规组［6.5%(2/31) vs. 30.4%(7/23)，χ2=3.878，P=0.049］。2组手术时间、术后应用止痛药、术后2周肌酐下降值差异均无统计学意义(P>0.05)。2组术后中位随访时间10个月(3~24个月)，未见腹透液渗漏、肠穿孔、腹腔内出血等并发症。结论输尿管软镜代替导丝引导腹透管置入，安全，可视，定位准确，可以降低腹透管相关并发症，并可以发现和处理腹腔内合并症。
Abstract:
ObjectiveTo explore the feasibility of peritoneal dialysis catheter placement assisted by flexible ureteroscope.MethodsA retrospective analysis was conducted on clinical data of 54 cases of endstage renal disease receiving peritoneal dialysis catheter placement from May 2019 to March 2023. The placement method was chosen by the patient. In the conventional group, 23 cases were guided by a metal guide wire for insertion of the peritoneal dialysis catheter, while in the flexible ureteroscope group, 31 cases were guided by flexible ureteroscope instead of guide wire for insertion of the peritoneal dialysis catheter. The success rate of catheterization, surgical time, use of postoperative analgesic, complications related to peritoneal dialysis catheter, and postoperative creatinine decrease were compared between the two groups.ResultsThe catheter placement was successfully performed in both groups. The total incidence of complications related to peritoneal dialysis catheter in the flexible ureteroscope group was lower than that in the conventional group ［6.5% (2/31) vs. 30.4% (7/23), χ2=3.878, P=0.049］. Between the conventional group and the flexible ureteroscope group, there were no statistically significant differences in the surgical time, postoperative analgesic usage, and the decrease of creatinine at 2 weeks after surgery (P>0.05). The median postoperative followup period was 10 months (range, 3-24 months) in the two groups, and there were no complications such as peritoneal leakage, intestinal perforation, or intraperitoneal bleeding.ConclusionThe placement of peritoneal dialysis catheter guided by the flexible ureteroscope instead of metal guide wire is a safe, visible, and accurate method, which can reduce complications related to peritoneal dialysis catheter, and detect and manage comorbidities in the abdominal cavity.

参考文献/References:

[1]中国腹膜透析置管专家组.中国腹膜透析置管指南.中华肾脏病杂志,2016,32(11):867-871.
[2]阳晓.递增式腹膜透析的临床应用.肾脏病与透析肾移植杂志,2022,31(3):252-253.
[3]Etkin Y,Woo K,Guidry L.Options for dialysis and vascular access creation.Surg Clin North Am,2023,103(4):673-684.
[4]《中国腹膜透析管理现状白皮书》项目组.中国腹膜透析管理现状白皮书.中华肾脏病杂志,2022,38(12):1076-1104.
[5]do Nascimento Lima H,Nerbass FB,Lugon JR,et al.Brazilian Dialysis Register Investigators.Characteristics and 1year survival of incident patients on chronic peritoneal dialysis compared with hemodialysis:a large 11year cohort study.Int Urol Nephrol,2023,55(8):2025-2033.
[6]Alshehri M,Alshehri A,Alfageeh A,et al.Who have a betterkidneyrelated quality of life: peritoneal dialysis or hemodialysis patients?A cross sectional study from Saudi Arabia.BMC Nephrol,2023,24(1):216.
[7]韩庆烽.腹膜透析置管术的新进展.中国血液净化,2022,21(5):309-311,345.
[8]黄巳悦,梁伟,王惠明.腹膜透析患者导管置入方式的探讨.临床肾脏病杂志,2022,22(2):147-151.
[9]Etkin Y,Woo K,Guidry L.Options for dialysis and vascular access creation.Surg Clin N Am,2023,103(4):673-684.
[10]Shah N,Goswell A,Cuesta C,et al.Comparing surgeonand nephrologistinserted Tenckhoff catheters:experience from a metropolitan centre in Sydney.Intern Med J,2023,53(10):1890-1895.
[11]于莉,周文华,杨月,等.老年终末期肾病患者不同紧急起始透析方式的预后分析.中华老年医学杂志,2021,40(7)842-846.
[12]成水芹,周婷婷,张志宏,等.超声引导下Seldinger法经皮穿刺腹膜透析置管术的临床应用.肾脏病与透析肾移植杂志,2020,29(5):433-437,457.
[13]Johnston G,Jin G,Morris CS.Imageguided tunneled peritoneal dialysis catheter placement.Cardiovasc Diagn Ther,2023,13(1):311-322.
[14]van Laanen JHH,Litjens EJ,Snoeijs M,et al.Introduction of advanced laparoscopy for peritoneal dialysis catheter placement and the outcome in a University Hospital.Int Urol Nephrol,2022,54(6):1391-1398.
[15]Keshvari A,Meshkati Yazd SM,Keramati MR,et al.Evaluation of the effectiveness of prophylactic omentopexy during laparoscopic insertion of peritoneal dialysis catheter:a casecontrol clinical trial.Int Urol Nephrol,2023,55(8):2083-2089.
[16]Gao X,Peng Z,Li E,et al.Modified minimally invasive laparoscopic peritoneal dialysis catheter insertion with internal fixation.Ren Fail,2023,45(1):2162416.
[17]陈嘉,屠义梅,汤劲松,等.筋膜闭合器辅助单孔腹腔镜完全腹膜外疝囊结扎术381例.中国微创外科杂志,2023,23(1):30-34.
[18]Sardiwalla II,Koto MZ,Kumar N,et al.Laparoscopic common bile duct exploration use of a rigid ureteroscope:a single institute experience.J Laparoendosc Adv S,2018,28(10):1169-1173.
[19]朱微,燕翔,蒋春明,等.输尿管镜辅助下腹膜透析管置入技术的应用.肾脏病与透析肾移植杂志,2012,21(2):126-128.
[20]周军,李伟健,曹月鹏,等.单通道输尿管镜辅助下腹膜透析管置入术与传统开腹置管临床疗效比较.国际泌尿系统杂志,2019,39(3):512-515.
[21]徐杰,严威,高文喜.经皮肾镜顺行输尿管软镜治疗特殊类型输尿管下段结石.中国微创外科杂志,2022,22(6):514-516.
[22]Wang R,Wang N,Tang J,et al.The safety and efficacy of MPRCTU combined with precise intraoperative ultrasonography guided flexible ureteroscope in the treatment of renal cystic disease.Exp Ther Med,2018,15(1):283-287.
[23]黄秀雯,裴娟,张冬,等.小旁切口缝合固定矫正腹膜透析导管漂管3例.中国中西医结合肾病杂志,2022,23(6):548-549,后插16.
[24]邵凌杰,李东奇,韩向军,等.腹膜透析管漂管复位中DSA引导的价值.介入放射学杂志,2021,30(11):1137-1139.
[25]张锁建,章旭,曹娟,等.改良的腹膜透析导管固定方法在腹透置管术中的应用.临床肾脏病杂志,2021,21(3):210-214.

备注/Memo

备注/Memo:
基金项目：上海市科学技术委员会医学创新研究专项(22Y11922700)；上海市卫生健康委员会卫生行业临床研究专项(202240386)；上海中医药大学预算内项目(2021LK063)**通讯作者，Email：dr_linshan@163.com ①脉管病二科②肾内科
更新日期/Last Update: 2024-04-15